Volume 21 Number 16

In this issue of EuroIntervention

Cardiogenic shock in women; PCSK9 inhibitors and non-culprit lesions; coronary microvascular dysfunction; residual shunt after PFO closure; the SESAME technique; TAVI in pure aortic regurgitation; design of the ALL-RISE trial; 3-year results from BIOMAG-I; scaffold therapy for infrapopliteal disease; carbon footprint of an angiogram; the Cathpax AIR cabin; and more

Capodanno D

free

Expert Consensus

SCAI/EAPCI/ACVC Expert Consensus Statement on Cardiogenic Shock in Women

Baron S, Chou J, Shah T, Vest A, Abbott JD, Alasnag M, Aurigemma C, Barbato E, Bellumkonda L, Bortnick A, Chieffo A, van Geuns R, Grines C, Halvorsen S, Hassager C, Kapur N, Naidu S, Ng V, Saw J, Lansky A

10.4244/EIJ-D-24-01126

free

Original Research

Changes in non-culprit coronary lesions with PCSK9 inhibitors: the randomised, placebo-controlled FITTER trial

Mensink F, Los J, Reda Morsy M, Oemrawsingh R, von Birgelen C, Ijsselmuiden A, Meuwissen M, Cheng J, van Wijk D, Smits P, Paradies V, van Wijk D, Rai H, ten Cate T, Camaro C, Damman P, van Nunen L, Dimitriu-Leen A, van Wely M, Cetinyurek-Yavuz A, Byrne R, van Royen N, van Geuns R

10.4244/EIJ-D-24-01065

Editorial comment

“He who has eyes to see, let him see”

Garcia-Garcia H

10.4244/EIJ-E-25-00036

free

Coronary flow and resistance patterns indexed by subtended myocardial mass in coronary microvascular dysfunction

Mahendiran T, Stalikas N, Gallinoro E, Keulards D, Sakai K, Bouisset F, Viscusi M, Corradetti S, Sonck J, van ’t Veer M, Wilgenhof A, Pijls N, Collet C, De Bruyne B

10.4244/EIJ-D-25-00229

Prevalence, classification, and treatment of residual shunt after patent foramen ovale closure

Ujka K, Pizzuto A, Giordano M, Di Muro F, Gaio G, Russo M, Sarubbi B, Meucci F, Santoro G

10.4244/EIJ-D-24-00856

Editorial comment

Does a positive bubble study after PFO closure matter: is it much ado about nothing or an indication for reintervention?

Horlick E, Abrahamyan L

10.4244/EIJ-E-25-00025

free

SESAME technique: septal scoring along the midline endocardium

McCabe J, Newton S, Danek B, Elison D, Chung C, Sheu R, Jelacic S, Condos G, Canovas E, Greenbaum A, Babaliaros V, Lederman R, Mackensen G

10.4244/EIJ-D-25-00131

Transcatheter aortic valve implantation in pure aortic regurgitation: one-year outcomes of the AURORA trial

Yu F, Peng X, Yao J, Yan Y, Corona S, Fu B, Wang S, Wang H, Zhuang X, Jiang Z, Zhao Y, Tang Y-D, Xu J, Li C, Chen H, Han K, Huang H, Guo L, Ben Ali W, Modine T, Jilaihawi H, Piazza N, Song G

10.4244/EIJ-D-25-00224

Trial Design

FFRangio-guided versus pressure wire-guided PCI: design and rationale of the multicentre, randomised ALL-RISE trial

Redfors B, Madhavan M, Kirtane A, Fearon W, Yeh R, Cohen D, Al-Lamee R, Jeremias A, Witberg G, Sharma R, Popma A, Kaki A, Froimovich A, Leon M

10.4244/EIJ-D-25-00200

Research Correspondence

Clinical outcomes of the third-generation resorbable magnesium scaffold for coronary artery lesions: three-year results of the BIOMAG-I study

Haude M, Wlodarczak A, van der Schaaf R, Torzewski J, Ferdinande B, Escaned J, Iglesias J, Bennett J, Toth G, Joner M, Toelg R, Wiemer M, Olivecrona G, Vermeersch P, Waksman R

10.4244/EIJ-D-25-00396

Retrievable scaffold therapy before paclitaxel drug-coated balloon angioplasty in infrapopliteal arteries: one-year outcomes of the DEEPER OUS Study

Lichtenberg M, Holden A, Scheinert D, Schmidt A, van Berg J, Piorkowski M, Hertting K, Thieme M, Andrassy M, Wissgott C, Miller L, Zeller T

10.4244/EIJ-D-24-00996

Carbon footprint of diagnostic coronary angiography

Leiszt C, Cheneau E, Vahdat B, Strube C, Thomas M, Felix D, Alessi S, Hanafia O, Saussereau M, Bialecki E, Panagides V

10.4244/EIJ-D-25-00175

A randomised controlled trial of the Cathpax AIR radioprotection cabin during cardiology procedures

Merieau A, Plessis J, Nael V, Letocart V, Manigold T, Piriou P, Le Ruz R, Fresse K, Guérin P

10.4244/EIJ-D-25-00125